Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Open: Feb 9, 16:24 PM 2012 
  NYSE  8081.26  1.72  Index Moved Down   NASDAQ  2927.23  11.37  Index Moved Up 
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for ALKS and CBRX...
    
  Alkermes Inc.  and    Columbia Laboratories Inc.
        
    
Diversification
Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Alkermes Inc. and Columbia Laboratories Inc. in the same portfolio (assuming nothing else is changed)
    
    
Correlation Coefficient
-0.04
 Parameters
Time Period1 Month [change]
DirectionNegative ALKS Moved Down vs CBRX
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
    

       

Alkermes Inc.

    
    
18.47
  
Alkermes Quote
Intraday
 
Alkermes Intraday Quote
One Month
(0.41)  Macroaxis: -2.17 Down   2.17%  
ALKS Macroaxis: United States NASDAQAlkermes Quote: Bear
Alkermes Inc.
Day Low18.44Open19.04
P/B Ratio2.71Market Cap2.396B
Volume561597SectorHealthcare
Last Close18.88FoundedYes
Short Ratio7.60Last Traded2/9/2012
Year High20.00Percent ChangePrice Moved Very Down 2.17%
EBITDA12.2MYear Low11.86
Absolute Change0.41 Price Moved DownTimeNot Applicable
Book Value6.974EPS-0.60
PEG Ratio0.13Employees600
Day High19.05IndustryDrug Delivery
Target Price21.90Current EPS-0.60
This Year EPS-0.62Next Year EPS-0.28
  

Columbia Laboratories Inc.

    
    
0.82
  
Columbia Quote
Intraday
 
Columbia Intraday Quote
One Month
(0.04)  Macroaxis: -4.12 Down   4.12%  
CBRX Macroaxis: United States NGMColumbia Quote: Bear
Columbia Laboratories Inc.
P/E5.48Day Low0.815
Open0.84P/B Ratio3.44
Market Cap71.1MVolume667428
SectorHealthcareLast Close0.85
Short Ratio9.00Last Traded2/9/2012
Year High4.31Percent ChangePrice Moved Totally Down 4.12%
EBITDA-1.3MYear Low0.64
Absolute Change0.04 Price Moved DownTimeNot Applicable
Book Value0.247EPS0.155
Employees22Day High0.85
Target Price1.50Current EPS0.155
This Year EPS0.05Next Year EPS0.05
Current PE5.48This Year PE17.00
Next Year PE17.00DividendNot Applicable